Skip to main content
. 2021 Apr 20;18(8):4376. doi: 10.3390/ijerph18084376

Table 2.

Positive rates of the serological tests in HCWs* included in the study from the University Hospital in Opole.

ELISA Test (Serological Assay) Outcomes OPOLE, Opole Voivod.
(nI=90)
IgA IgG IgM IgA/IgG IgA/IgM
(+) BR (+) BR (+) BR (+) BR (+) BR
8 3 1 1 2 2 0 0 1 0
(8.89%) (3.33%) (1.11%) (1.11%) (2.22%) (2.22%) (0.00%) (0.00%) (1.11%) (0.00%)
(nII=84)
IgA IgG IgM IgA/IgG IgA/IgM
(+) BR (+) BR (+) BR (+) BR (+) BR
7 2 2 0 6 4 1 0 1 0
(8.33%) (2.38%) (2.38%) (0.00%) (7.14%) (4.76%) (1.19%) (0.00%) (1.19%) (0.00%)
Analysis of two serial sera specimens (n = 84)
IgA IgG IgM IgA/IgG IgA/IgM
(+) BR (+) BR (+) BR (+) BR (+) BR
5 1 1 0 2 1 0 0 1 0
(5.95%) (1.19%) (1.19%) (0.00%) (2.38%) (1.19%) (0.00%) (0.00%) (1.19%) (0.00%)

* HCWs included nurses, physicians, laboratory diagnosticians, paramedics and other medical staff, (+)—seropositivity, BR—borderline ratio (+/−), nI—first blood collection (July 2020), nII—second blood collection (August 2020).